2022
DOI: 10.1016/j.ejim.2022.06.002
|View full text |Cite
|
Sign up to set email alerts
|

Clinical characteristics of BRASH syndrome: Systematic scoping review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
25
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 15 publications
(25 citation statements)
references
References 30 publications
0
25
0
Order By: Relevance
“…The phenomenon is now known as the "BRASH phenomenon" or "BRASH syndrome" [1]. This novel, under-recognized clinical entity is epitomized by a clinical quintet of bradycardia, renal failure, atrioventricular (AV) nodal blockade, shock, and hyperkalemia (BRASH) [1][2][3][4][5][6][7]. Although the incidence of BRASH syndrome is unknown, it is feasible for this uncommon manifestation to present in the emergency department due to the widespread use of atrioventricular (AV) nodal blockers for hypertension, chronic renal disease, and ischemic heart disease [2].…”
Section: Introductionmentioning
confidence: 99%
See 4 more Smart Citations
“…The phenomenon is now known as the "BRASH phenomenon" or "BRASH syndrome" [1]. This novel, under-recognized clinical entity is epitomized by a clinical quintet of bradycardia, renal failure, atrioventricular (AV) nodal blockade, shock, and hyperkalemia (BRASH) [1][2][3][4][5][6][7]. Although the incidence of BRASH syndrome is unknown, it is feasible for this uncommon manifestation to present in the emergency department due to the widespread use of atrioventricular (AV) nodal blockers for hypertension, chronic renal disease, and ischemic heart disease [2].…”
Section: Introductionmentioning
confidence: 99%
“…The prevalence of BRASH syndrome is greater than what has been documented in the medical literature. When a patient with modest hyperkalemia develops substantial bradycardia, emergency doctors should have a high degree of suspicion for BRASH syndrome [1,3,4]. reports and series, and 15 conference abstracts revealed that patients' symptoms could not be relieved by atropine or glucagon; 59.5% needed inotropes or chronotropes instead, and 7.1% of people died due to BRASH syndrome [3].…”
Section: Introductionmentioning
confidence: 99%
See 3 more Smart Citations